Atul Awasthi

Atul Awasthi

Pfizer Inc. - New York / United States
Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences
AD Scientific Index ID: 4541284
-
person_outline Atul Awasthi's MOST POPULAR ARTICLES
1-) Formulations comprising ceftiofur and ketoprofen or ceftiofur and benzyl alcoholM Razzak, A Johnson, J Goswami, A AwasthiUS Patent App. 12/621,208, 2010452010
2-) An overview on chemical derivatization and stability aspects of selected avermectin derivativesA Awasthi, M Razzak, R Al-Kassas, J Harvey, S GargChemical and Pharmaceutical Bulletin 60 (8), 931-944, 2012372012
3-) Isolation and characterization of degradation products of moxidectin using LC, LTQ FT-MS, H/D exchange and NMRA Awasthi, M Razzak, R Al-Kassas, DR Greenwood, J Harvey, S GargAnalytical and bioanalytical chemistry 404, 2203-2222, 2012232012
4-) Separation and identification of degradation products in eprinomectin formulation using LC, LTQ FT-MS, H/D exchange, and NMRA Awasthi, M Razzak, R Al-Kassas, DR Greenwood, J Harvey, S GargJournal of pharmaceutical and biomedical analysis 63, 62-73, 2012222012
5-) Selective separation and characterisation of stress degradation products and process impurities of prucalopride succinate by LC-QTOF-MS/MSBS Mahamuni, A Jajula, A Awasthi, PD Kalariya, MVNK TalluriJournal of pharmaceutical and biomedical analysis 125, 219-228, 2016212016